No Detail Found!

Lagendorff`s heart preparation: Evaluation of muscarinic receptor activity of doxorubicin.

Author(s)
Iqbal Ahsun Department of Anaesthesiology, Karachi Medical & Dental College and Abbasi Shaheed Hospital, Karachi, Pakistan
Fareeda Islam Department of Pharmacy, Hamdard University, Karachi, Pakistan
Syed Muhammad Shamim Department of Pharmacology & Therapeutics Karachi Medical & Dental College, Karachi, Pakistan
Abstract
Doxourbicin (Dox) is an effective anticancer chemotherapeutic agent, for the treatment of several different human cancers, causes an insidious and delayed cardiotoxicity. Its use is limited, as cardiac toxicity occurs above a cumulative dose 450 mgm-2 and incidence of this toxicity increases markedly at dose2 greater than 550 mgm-2 Pre-clinical investigations are attempting to elucidate the doxorubicin induced cardiotoxcity drugs are used to scavenge the toxicity or to determine the possible mechanisms of this cardiac toxicity. Role of autonomic nervous system in this regard has extensively been investigated. We have tried to find the physiological interactions of DOX with muscarinic receptors in presence of Atropine (Antagonist) and evaluated the effects for up and down regulation of muscarinic receptors. The results showed synergistic activity of DOX with atropine and hence DOX is said to be a muscarinic, antagonist.
Publication Details
Page(s) 76-81
DOI DOI not available
Published Journal: Professional Medical Journal, Volume: 14, Issue: 1, Year: 2007

Request the full text from PASTIC

0

Citations

0

Downloads

24

Views